234 related articles for article (PubMed ID: 30396012)
1. The Toll-Like Receptor 2 agonist PEG-Pam
Ernest M; Hunja C; Arakura Y; Haraga Y; Abkallo HM; Zeng W; Jackson DC; Chua B; Culleton R
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):451-458. PubMed ID: 30396012
[TBL] [Abstract][Full Text] [Related]
2. Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.
Peng X; Keitany GJ; Vignali M; Chen L; Gibson C; Choi K; Huang F; Wang R
J Immunol; 2014 Aug; 193(3):1268-77. PubMed ID: 24958899
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.
Belnoue E; Voza T; Costa FT; Grüner AC; Mauduit M; Rosa DS; Depinay N; Kayibanda M; Vigário AM; Mazier D; Snounou G; Sinnis P; Rénia L
J Immunol; 2008 Dec; 181(12):8552-8. PubMed ID: 19050274
[TBL] [Abstract][Full Text] [Related]
4. The intradermal route for inoculation of sporozoites of rodent malaria parasites for immunological studies.
Inoue M; Culleton RL
Parasite Immunol; 2011 Feb; 33(2):137-42. PubMed ID: 21226727
[TBL] [Abstract][Full Text] [Related]
5. Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice.
Moneriz C; Marín-García P; Bautista JM; Diez A; Puyet A
Malar J; 2011 Apr; 10():103. PubMed ID: 21518429
[TBL] [Abstract][Full Text] [Related]
6. The TLR2 is activated by sporozoites and suppresses intrahepatic rodent malaria parasite development.
Zheng H; Tan Z; Zhou T; Zhu F; Ding Y; Liu T; Wu Y; Xu W
Sci Rep; 2015 Dec; 5():18239. PubMed ID: 26667391
[TBL] [Abstract][Full Text] [Related]
7. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment.
Belnoue E; Costa FT; Frankenberg T; Vigário AM; Voza T; Leroy N; Rodrigues MM; Landau I; Snounou G; Rénia L
J Immunol; 2004 Feb; 172(4):2487-95. PubMed ID: 14764721
[TBL] [Abstract][Full Text] [Related]
8. Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii.
Mout R; Xu ZD; Wolf AK; Jo Davisson V; Jarori GK
Malar J; 2012 Feb; 11():54. PubMed ID: 22361388
[TBL] [Abstract][Full Text] [Related]
9. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.
Labaied M; Harupa A; Dumpit RF; Coppens I; Mikolajczak SA; Kappe SH
Infect Immun; 2007 Aug; 75(8):3758-68. PubMed ID: 17517871
[TBL] [Abstract][Full Text] [Related]
11. Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model.
Bhardwaj J; Siddiqui AJ; Goyal M; Prakash K; Soni A; Puri SK
Acta Trop; 2016 Jun; 158():130-138. PubMed ID: 26925772
[TBL] [Abstract][Full Text] [Related]
12. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
[TBL] [Abstract][Full Text] [Related]
13. Vaccination using normal live sporozoites under drug treatment.
Rénia L; Grüner AC; Mauduit M; Snounou G
Methods Mol Biol; 2013; 923():567-76. PubMed ID: 22990805
[TBL] [Abstract][Full Text] [Related]
14. Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes.
Zhu F; Liu T; Zhao C; Lu X; Zhang J; Xu W
J Immunol; 2017 Jan; 198(1):300-307. PubMed ID: 27903741
[TBL] [Abstract][Full Text] [Related]
15. The Plasmodium yoelii microgamete surface antigen (PyMiGS) induces anti-malarial transmission blocking immunity that reduces microgamete motility/release from activated male gametocytes.
Tachibana M; Ishino T; Tsuboi T; Torii M
Vaccine; 2018 Nov; 36(49):7463-7471. PubMed ID: 30420038
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory role of toll-like receptors agonists in Plasmodium yoelii liver stage development.
Chen J; Xu W; Zhou T; Ding Y; Duan J; Huang F
Parasite Immunol; 2009 Aug; 31(8):466-73. PubMed ID: 19646211
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.
Sack BK; Keitany GJ; Vaughan AM; Miller JL; Wang R; Kappe SH
PLoS Pathog; 2015 May; 11(5):e1004855. PubMed ID: 25974076
[TBL] [Abstract][Full Text] [Related]
18. Daily Plasmodium yoelii infective mosquito bites do not generate protection or suppress previous immunity against the liver stage.
Pollock T; Leitao R; Galan-Rodriguez C; Wong KA; Rodriguez A
Malar J; 2011 Apr; 10():97. PubMed ID: 21501513
[TBL] [Abstract][Full Text] [Related]
19. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
[TBL] [Abstract][Full Text] [Related]
20. Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.
Low LM; Ssemaganda A; Liu XQ; Ho MF; Ozberk V; Fink J; Sundac L; Alcorn K; Morrison A; O'Callaghan K; Gerrard J; Stanisic DI; Good MF
Infect Immun; 2019 Jan; 87(1):. PubMed ID: 30323025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
